IV Dosing, Wt-Based

Loading...

References

  1. Javier J Lasa. Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.. Circulation, 2025
  2. Anne-Grete Märtson. The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments.. The Lancet. Infectious diseases, 2025
  3. Anne Coste. Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review.. Critical care (London, England), 2025
  4. NA. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney international, 2024
  5. Jennifer J Griggs. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021
  6. Alexis A Topjian. Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.. Circulation, 2020
  7. S. Robinson. A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial. Critical Care, 2013
  8. K. Hourdequin. Toxicity of chemotherapy dosing using actual body weight in obese versus normal-weight patients: A systematic review and meta-analysis.. Journal of Clinical Oncology, 2012
  9. R. Raschke. The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram. Annals of Internal Medicine, 1993